Home » Topics » Regulatory » Patents

Patents
RSS

Sankyo discloses agents for diabetes and related complications

Nov. 28, 1997

Bayer patents new antiatherosclerotic agents

Nov. 28, 1997

Glutamate antagonists discovered at BASF

Nov. 28, 1997

Lilly prepares new benzothiophenes

Nov. 28, 1997

Cathepsin L inhibitors with broad therapeutic potential from Takeda

Nov. 27, 1997

WB-2663B, a novel immunosuppressant isolated from Pseudomonas

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

New V1 antagonists disclosed by Yamanouchi

Nov. 27, 1997

New erythromycins discovered at Roussel Uclaf

Nov. 27, 1997

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...